Calcaratarin D, a labdane diterpenoid, attenuates bleomycin-induced pulmonary fibrosis by blocking Wnt/β-catenin signaling pathway
Open Access
- 29 April 2025
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 216, 107756
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation (A-0006243-00-00)
- National University of Singapore (GAP2002023\u201303\u201311)
- National University Health System (DDOP-E-559-00-0004-01, A-8002090-00-00)
This publication has 49 references indexed in Scilit:
- Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarizationJournal of Ethnopharmacology, 2023
- Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung diseaseBiochemical Pharmacology, 2023
- Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent mannerCell Reports, 2023
- Elevated Wnt2 and Wnt4 activate NF-κB signaling to promote cardiac fibrosis by cooperation of Fzd4/2 and LRP6 following myocardial infarctionEBioMedicine, 2021
- Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPDPharmacological Research, 2020
- The identification of naturally occurring labdane diterpenoid calcaratarin D as a potential anti-inflammatory agentEuropean Journal of Medicinal Chemistry, 2019
- Repurposing of gamma interferon via inhalation deliveryAdvanced Drug Delivery Reviews, 2018
- The WNT signaling pathways in wound healing and fibrosisMatrix Biology, 2018
- Labdane diterpenoids as potential anti-inflammatory agentsPharmacological Research, 2017
- YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt ResponseCell, 2014